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Riann Collar, PA-S
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Abstract

Literature Review

There is discrepancy amongst organizations and the medical community
whether bimanual pelvic examinations should be performed in
asymptomatic women for routine screening. The purpose of this literature
review was to determine whether bimanual pelvic examinations are
beneficial for screening for ovarian cancer in comparison to no screening.
In addition, research was conducted to see if healthcare providers’
professional beliefs align with the evidence and national
recommendations, to determine women’s thoughts and beliefs regarding
pelvic examinations, and identify other screening methods if bimanual
pelvic exams are determined to be an invalid screening tool. Throughout
reviewing peer reviewed articles and high-quality evidence, it was found
that bimanual pelvic exams have low sensitivity for screening, which is not
ideal due to false positives; however, several researchers still feel this is
an important screening tool. Also, many providers still consider the pelvic
exam beneficial when performed annually on asymptomatic women as part
of a well-woman exam and continue to perform them routinely in the office.
Research also shows that the majority of women do not feel uncomfortable
or pain during a pelvic exam and the majority wish to continue having them
performed on a regular basis. Combinations of different screening
methods such as pelvic examination with serum CA-125 annually and
serum CA-125 with transvaginal ultrasound annually were found to be
effective in screening for ovarian cancer in asymptomatic women.

• Abenhaim, Titus-Ernstoff, & Cramer (2007) found that women with ovarian cancer were
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• The PLCO did not find that CA-125 or TVU screenings significantly reduces mortality but

Introduction
•

Prior to 2013, Pap testing was performed annually for cervical cancer
screening and typically a pelvic examination would be performed in
addition to a Pap every year

• In 2013, the American College of Obstetricians and Gynecologists
(ACOG) changed the recommendations for performing Pap testing from
annually to every 3 years alone or 5 years if co-testing with HPV

•

Discussion

Application to Clinical Practice

•

• Providers should discuss the potential risks and benefits of performing

significantly less likely to have an annual medical visit and pelvic exam (Table 1)

– there is not enough evidence to be for or against routine
screening with pelvic examination

• The Prostate, Lung, Colorectal and Ovarian cancer screening (PLCO) trial found
sensitivity for ovarian palpation for cancer was 5.1%, specificity was 99.0%; pelvic
exams were removed from the study after 5 years (Doroudi, Kramer, & Pinsky, 2016)

– unsure of the benefits versus the harms because of the lack
of studies

• The study conducted by Padilla, Radosevich, and Milad (2000) found adnexal masses
with bimanual palpation 8% of the time (sensitivity was 15-33%, specificity was 79-92%)
while women were under general anesthesia with a Foley placed

•

The American College of Physicians (ACP) gives a strong recommendation to not
perform pelvic exams on asymptomatic women based off low sensitivity, additional
costs, and possible harm. Most literature that the recommendation is based on is >10
years old (Qaseem, Humphrey, Harris, Starkey, & Denberg, 2014).

• Henderson, Harper, Gutin, Saraiya, Chapman, & Sawaya (2013) surveyed ob/gyn
providers with 4 vignettes with asymptomatic women not needing a pap; nearly all would
perform a pelvic exam (Figure 1)

• Kling et al. (2017) found that 92.4% of women had pelvic exams performed on a regular
basis either annually or every 2-5 years, and after reviewing the new ACP guidelines,
86.7% will continue regular pelvic exams

– has not given a recommendation with a Grade I for
insufficient evidence (USPSTF, 2017)
•

both have a higher sensitivity than pelvic exams; found a 35% reduction in mortality
which was not statistically significant (p=0.05) (Buys et al., 2011)

• Van Nagell et al. (2007) found TVU had PPV of 27.1% and NPV of 99.9%.
– Those with annual screenings with TVU and diagnosed with ovarian cancer had a
92.1% 2-year survival rate in comparison with the general population with unknown or
no screenings had a 2-year survival rate of 70.7%

– 82% of the women in the study with ovarian cancer were found in stage I or stage II
compared to the general population of women diagnosed with stage I or II being 34%

• The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) showed optimistic
results by combining TVU and CA-125 with sensitivity of 89.4%, specificity of 99.8%,
and PPV of 43.3% (Menon et al., 2009)

The American Academy of Family Physicians (AAFP)
recommends against pelvic exams

– Grade D for evidence of little benefit and possible harm
(AAFP, 2017)
•

Overall, current evidence that supports performing pelvic
examinations is not strong and is outdated

•

Ovarian cancer is usually detected late with a low 5-year
survival prognosis, and if bimanual exams may find some of
these cases earlier, it is worth performing

•

Pelvic exams have a high benign findings rate which can lead
to additional cost, testing, anxiety, and possibly unnecessary
surgery, however, these are necessary to find some cases of
ovarian cancer early

•

All studies reviewed that were conducted to evaluate
provider’s practices and beliefs show that the majority of
providers, especially OB/GYN, still feel bimanual pelvic exams
are an important part of the well-woman visit

•

bimanual pelvic examinations and reach a mutual decision

• Each woman should be treated as their own individual with all their
medical history taken into account in the decision making

• It should not be assumed that bimanual exams do not need to be
performed anymore nor that they should be performed annually
without discussion

• If a woman does not wish to decide or would like professional advice,
based on common practice of expert providers, it should be advised to
perform them annually

•

ACOG recommends annual pelvic exams at well-woman visits
based on expert opinion, discussion should be had between
patient/provider and come to a shared decision (ACOG, 2016)

•

• Combining serum CA-125, bimanual pelvic examination, and transvaginal ultrasound for
ovarian cancer screening had 100% sensitivity, 99.7% specificity, and PPV of 22%
which is effective for screening (Adonakis et al., 1996) (Table 2)

The U.S. Preventive Services Task Force (USPSTF) states:

Combining different screening methods (serum CA-125, TVU,
pelvic exam) for ovarian cancer has proven to be effective but
cost was not considered, further study needs to be completed
and insurance coverage would be necessary for other
screening methods

It is not clearly defined if pelvic examinations should be continued
annually for ovarian cancer screening

Table 2: Specificity, sensitivity and positive predictive value

Note: Adapted from “A combined approach for the early detection of ovarian cancer in asymptomatic
women”, by G. L. Adonakis, E. Paraskevaidis, S. Tsiga, K. Seferiadis, and D. E. Lolis, 1996, European
Journal of Obstetrics & Gynecology and Reproductive Biology, 65, p. 221-225. Copyright: 1996 by
Elsevier Science Ireland Ltd.
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Figure 1: Patient vignettes and thoughts of
practitioners on pelvic exam

Table 1: Ovarian cancer risk based on medical visit frequency, pelvic examination, and type
of healthcare provider

Statement of the Problem

•
•
•

• 70% of ovarian cancer cases are diagnosed late, usually beyond the
possibly of a cure (Chagas, E. & Brazil, A., 2016)

•

• Most women with tumors of the ovaries or fallopian tubes are
asymptomatic and approximately 75% of ovarian cancer diagnoses are
metastatic with poor survival rates even with treatment (Adonakis,
Paraskevaidis, Tsiga, Seferiadis, & Lolis, 2016)

•
•

• Ovarian cancer that is found only in the ovary and has not metastasized
has a 5-year survival rate of 92% compared to a 5-year survival rate of
30% with metastatic ovarian cancer

•
•

• A screening tool with high sensitivity is important to detect these findings
early

•

• Since the frequency of Pap tests has decreased, there has been much
debate within the medical community on the frequency of pelvic
examinations or if they are even beneficial at all in asymptomatic adult
women

•

• In asymptomatic women who receive Pap screenings every 3 or 5 years,
are pelvic exams beneficial for ovarian cancer screening in comparison
to no screening?
national recommendations?

• What are women’s thoughts and beliefs regarding pelvic examinations?
• If pelvic exams are not beneficial, what other screening methods are
available for ovarian cancer?
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